Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.
Contains 3 vials each with 100 CFU of inactivated mycoplasma particles and 2 negative controls. For extensive validation of detection limit and robustness.